Old Web
English
Sign In
Acemap
>
authorDetail
>
Sarah M. Glass
Sarah M. Glass
GlaxoSmithKline
FCGR3A
Oncology
Pathology
FCGR2A
Ofatumumab
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Impact of FCGR3A V158F and FCGR2A H131R variants on ofatumumab efficacy in DLBCL and CLL.
2015
Journal of Clinical Oncology
Sarah M. Glass
Pamela L. St. Jean
Kay Murphy
Louise Clapham
Eddie Carden
Astrid McKeown
Michele Gorczyca
Oliver Wright
Michael Fennessy
Ira V. Gupta
Colin F. Spraggs
Show All
Source
Cite
Save
Citations (0)
Accurate interrogation of FCGR3A rs396991 in European and Asian populations using a widely available TaqMan genotyping method.
2015
Pharmacogenetics and Genomics
Kay Murphy
Heather A. Niederer
Karen S King
Elizabeth C. Harris
Sarah M. Glass
Charles J. Cox
Show All
Source
Cite
Save
Citations (1)
1